AMRN – Amarin Corporation Vascepa REDUCE-IT outcomes trial

When:
March 18, 2019 all-day
2019-03-18T00:00:00-04:00
2019-03-19T00:00:00-04:00

$AMRN – Amarin Corporation Vascepa REDUCE-IT outcomes trial

An Amarin investor/analyst conference call to discuss the presented data, including data from the late-breaker presentation, will be held on Monday, March 18 at 4:00 p.m. Central Time (CT) / 5:00 p.m. Eastern Time (ET) with several prominent physicians.

 

Important New Data on Vascepa® (Icosapent Ethyl) from the REDUCE-IT™ Trial to Be Presented Regarding Reduction in Total Ischemic Events

Leave a Reply